Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR).
Špaček M, Smolej L, Šimkovič M, Nekvindová L, Křístková Z, Brychtová Y, Panovská A, Mašlejová S, Bezděková L, Écsiová D, Vodárek P, Zuchnická J, Mihályová J, Urbanová R, Turcsányi P, Lysák D, Novák J, Brejcha M, Líkařová T, Vodička P, Baranová J, Trněný M, Doubek M; Czech CLL Study Group. Špaček M, et al. Among authors: turcsanyi p. Br J Haematol. 2023 Jul;202(1):40-47. doi: 10.1111/bjh.18736. Epub 2023 Mar 27. Br J Haematol. 2023. PMID: 36971061
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group.
Šimkovič M, Turcsányi P, Špaček M, Mihályová J, Ryznerová P, Maco M, Vodárek P, Écsiová D, Poul H, Móciková H, Zuchnická J, Panovská A, Lekaa M, Oršulová M, Prchlíková A, Stejskal L, Mašlejová S, Brychtová Y, Bezděková L, Papajík T, Lysák D, Trněný M, Smolej L, Doubek M. Šimkovič M, et al. Among authors: turcsanyi p. Ann Hematol. 2023 Apr;102(4):811-817. doi: 10.1007/s00277-023-05147-z. Epub 2023 Feb 27. Ann Hematol. 2023. PMID: 36847805 Free PMC article.
Revisiting Richter transformation in the era of novel CLL agents.
Petrackova A, Turcsanyi P, Papajik T, Kriegova E. Petrackova A, et al. Among authors: turcsanyi p. Blood Rev. 2021 Sep;49:100824. doi: 10.1016/j.blre.2021.100824. Epub 2021 Mar 12. Blood Rev. 2021. PMID: 33775465 Free article. Review.
Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks.
Mikulkova Z, Manukyan G, Turcsanyi P, Kudelka M, Urbanova R, Savara J, Ochodkova E, Brychtova Y, Molinsky J, Simkovic M, Starostka D, Novak J, Janca O, Dihel M, Ryznerova P, Mohammad L, Papajik T, Kriegova E. Mikulkova Z, et al. Among authors: turcsanyi p. Sci Rep. 2021 Jan 11;11(1):322. doi: 10.1038/s41598-020-79121-4. Sci Rep. 2021. PMID: 33431934 Free PMC article.
External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score.
Smolej L, Turcsányi P, Kubová Z, Zuchnická J, Mihályová J, Šimkovič M, Vodárek P, Krčméryová M, Móciková H, Brejcha M, Špaček M; Czech CLL Study Group. Smolej L, et al. Among authors: turcsanyi p. Br J Haematol. 2021 Apr;193(1):133-137. doi: 10.1111/bjh.17074. Epub 2020 Sep 10. Br J Haematol. 2021. PMID: 33280081 Free article.
18 results